Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era

Kenrick Ng, Krishna Vinnakota, Anand Sharma, Joanne Cresswell, John Kelly, Prokar Dasgupta, Nikhil Vasdev

Research output: Contribution to journalArticlepeer-review

5 Downloads (Pure)

Abstract

The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this problem, and several novel biomarkers have shown promise for this purpose.
Original languageEnglish
Number of pages3
JournalNature Reviews Urology
DOIs
Publication statusPublished - 17 Dec 2020

Fingerprint

Dive into the research topics of 'Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era'. Together they form a unique fingerprint.

Cite this